Outcomes of Consecutive Patients With Newly Diagnosed Myeloma Requiring Dialysis: Dialysis Independence is Associated with Rapid Myeloma Response and Predicts for Longer Survival

Meletios A Dimopoulos; Anastasia Pouli; Μαρία Ρούσσου; Maria Gavriatopoulou; Nikolaos Kanellias; Despina Fotiou; Magdalini Migkou; Evangelos Eleutherakis‐Papaiakovou; Dimitrios C. Ziogas; Ioannis Panagiotidis; Erasmia Psimenou; Charis Matsouka; Despoina Mparmparousi; Stavroula Giannouli; Evangelos Terpos; Efstathios Kastritis

doi:10.1016/j.clml.2017.03.114

Article2016

Outcomes of Newly Diagnosed Myeloma Patients Requiring Dialysis: Dialysis Independence Is Associated with Rapid Myeloma Response and Predicts for Longer Survival

Meletios A Dimopoulos, Μαρία Ρούσσου, Maria Gavriatopoulou, Despina Fotiou, Dimitriοs Ziogas, Magdalini Migkou, Ioannis Panagiotidis, Evangelos Eleutherakis‐Papaiakovou, Nikolaos Kanellias, Erasmia Psimenou, John Boletis, Dimitra Bacharaki, Despoina Mparmparoussi, Charis Matsouka, Stavroula Giannouli, Evangelos Terpos, Efstathios Kastritis

Letter2017

Outcomes of newly diagnosed myeloma patients requiring dialysis: renal recovery, importance of rapid response and survival benefit

Meletios A Dimopoulos, Μαρία Ρούσσου, Maria Gavriatopoulou, Despina Fotiou, Dimitrios C. Ziogas, Magdalini Migkou, Ioannis Panagiotidis, Evangelos Eleutherakis‐Papaiakovou, Nikos Kanellias, Erasmia Psimenou, Smaragdi Marinaki, Dimitra Bacharaki, Despoina Mparmparoussi, C. Matsouka, Stavroula Giannouli, Evangelos Terpos, Efstathios Kastritis

Article2024

Outcomes of Newly Diagnosed Multiple Myeloma Patients Requiring Dialysis

Despina Fotiou, Foteini Theodorakakou, Eirini Solia, Maria Gavriatopoulou, Vasiliki Spiliopoulou, Ioannis Ntanasis‐Stathopoulos, Panagiotis Malandrakis, Erasmia Psimenou, Nikolaos Kanellias, Μαρία Ρούσσου, Magdalini Migkou, Evangelos Eleutherakis‐Papaiakovou, Evangelos Terpos, Meletios A Dimopoulos, Efstathios Kastritis

Article2007

The Ratio of Angiopoietin-1 to Angiopoietin-2 Is Reduced and Predicts Independently for Survival in Newly Diagnosed Patients with Multiple Myeloma.

Meletios A Dimopoulos, Konstantinos Anargyrou, Eirini Katodritou, Efstathios Kastritis, Anastasia Pouli, Evridiki Michali, Evgenia Verrou, Anastasia Banti, Konstantinos Tsionos, Aikaterini Stefanoudaki, Konstantinos Zervas, Evangelos Terpos

Letter2011

Zoledronic acid for all patients with newly diagnosed multiple myeloma?

Evangelos Terpos, Meletios A Dimopoulos

Outcomes of Consecutive Patients With Newly Diagnosed Myeloma Requiring Dialysis: Dialysis Independence is Associated with Rapid Myeloma Response and Predicts for Longer Survival

Discussion(0)

Related publications

Outcomes of Newly Diagnosed Myeloma Patients Requiring Dialysis: Dialysis Independence Is Associated with Rapid Myeloma Response and Predicts for Longer Survival

Outcomes of newly diagnosed myeloma patients requiring dialysis: renal recovery, importance of rapid response and survival benefit

Outcomes of Newly Diagnosed Multiple Myeloma Patients Requiring Dialysis

The Ratio of Angiopoietin-1 to Angiopoietin-2 Is Reduced and Predicts Independently for Survival in Newly Diagnosed Patients with Multiple Myeloma.

Zoledronic acid for all patients with newly diagnosed multiple myeloma?